Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lihe Hongxin Venture Capital Partnership is a Shenzhen-based venture capital firm that focuses on early and growth-stage investments in the high-tech and life sciences sectors. The firm operates as an investment vehicle under the Leaguer Group, which was established by the Research Institute of Tsinghua University in Shenzhen. Its investment portfolio is heavily weighted toward biotechnology, medical devices, and innovative healthcare solutions, leveraging strong academic ties for deal flow. Beyond capital, the partnership provides incubation services and strategic guidance to help startups navigate the Chinese regulatory and commercial landscape. Key areas of interest include molecular diagnostics, biopharmaceuticals, and advanced medical instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lihehongxin Venture Capital Partnership.